Drug Delivery Systems Market to Grow at a CAGR of 7.3% from 2025 to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Future Market Size Estimation For The Drug Delivery Systems Market Covering 2025–2034?

The drug delivery systems market has witnessed significant expansion in recent years. This market is set to increase from $41.17 billion in 2024 to $44.21 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.4%. The historical growth trajectory is primarily due to escalating research and development investments, a rise in the prevalence of chronic diseases, the proliferation of biologics and monoclonal antibodies, substantial demand for non-invasive delivery methods, and the ongoing requirement for better patient compliance and adherence.

The drug delivery systems market is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $58.64 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.3%. This projected growth during the forecast timeframe is primarily driven by factors such as an increasing emphasis on personalized medicine, a widening array of complex and sensitive drugs under development, the escalating incidence of rare and orphan diseases, supportive regulatory frameworks for novel delivery systems, and an aging global populace. Key developments expected within this period encompass the creation of nanotechnology-enabled drug delivery mechanisms, advancements in controlled-release and sustained-release methods, progress in biologics and biosimilars necessitating specific administration techniques, the incorporation of intelligent drug delivery devices, and the formulation of targeted delivery systems specifically for cancer treatment.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24523&type=smp

What Are The Drivers Pushing New Developments In The Drug Delivery Systems Market?

The increasing occurrence of respiratory ailments is expected to drive the expansion of the drug delivery systems market in the future. Respiratory disorders are conditions that disrupt the normal operation of the lungs and airways, leading to labored breathing and decreased oxygen intake. The surge in respiratory disorders stems from rising air pollution, which persistently exposes populations to toxic airborne particles and gases that compromise lung function and contribute to the onset and worsening of respiratory conditions. Drug delivery systems play a crucial role in the effective treatment and management of respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and cystic fibrosis. These sophisticated systems guarantee that medications are delivered directly into the lungs, thereby enhancing therapeutic outcomes while simultaneously reducing systemic side effects. For instance, in March 2025, the UK Health Security Agency, a UK-based government agency, reported that tuberculosis cases in England rose by 13% in 2024, climbing to 5,480 cases from 4,850 cases in 2023. Thus, the escalating prevalence of respiratory disorders will propel the growth of the drug delivery systems market.

What Are The Major Segment Categories Driving The Drug Delivery Systems Market Growth?

The drug delivery systems market covered in this report is segmented –

1) By Type: Injection-Based Drug Delivery System, Oral Drug Delivery System, Inhalation Or Pulmonary Drug Delivery System, Transmucosal Drug Delivery System

2) By Material: Polymer-Based Drug Delivery Systems, Lipid-Based Drug Delivery Systems, Inorganic Drug Delivery Systems, Biologics-Based Drug Delivery Systems, Hybrid Drug Delivery Systems

3) By Application: Infectious Disease, Oncology, Ophthalmology, Urology, Diabetes, Central Nervous System, Other Applications

4) By End-User: Hospitals, Pharmaceutical Companies, Research Institutions, Homecare Settings, Diagnostic Laboratories

Subsegments:

1) By Injection-Based Drug Delivery System: Intravenous (IV), Intramuscular (IM), Subcutaneous (SC), Intradermal, Intrathecal, Depot Injections, Needle-Free Injectors

2) By Oral Drug Delivery System: Tablets, Capsules, Solutions And Syrups, Suspensions, Powders And Granules, Modified Release Formulations

3) By Inhalation Or Pulmonary Drug Delivery System: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers, Soft Mist Inhalers, Nasal Sprays

4) By Transmucosal Drug Delivery System: Buccal Delivery, Sublingual Delivery, Rectal Delivery, Vaginal Delivery, Nasal Mucosal Delivery

Which Market Trends Are Creating New Opportunities In The Drug Delivery Systems Industry?

Major companies operating in the drug delivery systems market are concentrating on developing advanced solutions, such as metal-free, multidose nasal spray pumps, to enhance user comfort and ease of handling. Metal-free, multidose nasal spray pumps are devices designed to deliver multiple doses of medication through the nasal passage without utilizing any metal components, ensuring both safety and compatibility with diverse formulations. For instance, in January 2023, Aptar Pharma, a US-based pharmaceutical company, introduced the APF Futurity metal-free, multidose nasal spray pump. This nasal spray pump is engineered for delivering nasal saline and other comparable over-the-counter products, with a strong emphasis on its recyclability. It represents Aptar Pharma’s first highly recyclable nasal spray pump, achieving a Class AA certification from cyclos-HTP for European recycling systems. Made entirely from polyolefin materials and devoid of metal components or recycling contaminants, it helps streamline recycling and improve recyclate quality. Utilizing Aptar Pharma’s Advanced Preservative Free technology, this metal-free pump ensures precise and consistent dosing with gentle operation, without compromising on ease of use or effectiveness.

Who Are The Prominent Global Companies Shaping The Drug Delivery Systems Market?

Major companies operating in the drug delivery systems market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories Inc., Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Tandem Diabetes, Pacira Biosciences, Poseida Therapeutics, Universal Stabilization Technologies Inc., Spectrum Pharmaceuticals Inc., VasoRx Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/drug-delivery-systems-global-market-report

How Is Drug Delivery Systems Market Demand Varying Across Different Regions?

North America was the largest region in the drug delivery system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Drug Delivery Systems Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24523&type=smp

Browse Through More Reports Similar to the Global Drug Delivery Systems Market 2025, By The Business Research Company

Pharmaceutical Drug Delivery Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Advanced Drug Delivery Systems Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/advanced-drug-delivery-systems-global-market-report

Electronic Drug Delivery Systems Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/electronic-drug-delivery-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795